TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Postprandial plasma BCAA patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of TEAEs leading to discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Histopathology scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of ERAS in elderly patients undergoing colorectal resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: earlier breast development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: pubic hair development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Achievement of disease-specific goals
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cerebral edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological function (NIHSS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of falls prevented
Endpoint domain: Resource use
Primary endpoint: Number of steps/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence in the RFU group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of diagnosis, referral and treatment for depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CVP measurement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent weight loss at week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with procedure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NIH‐CPSI pain sub‐score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in back and leg pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of completing OSCE stations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Support for implementation of video in dental education
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: major recurrent cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: awake cough frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative dietary scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: RT distractor effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-speed running
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative Energy Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trabecular volumetric BMD of the tibia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: trabecular number of the radius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: trabecular number of the tibia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Arginine plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Arginine to ADMA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of drug-positive samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FVC (Forced Vital Capacity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Schiff sensitivity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of defecation episodes per daytime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of defecation episodes per night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day functional independence
Endpoint domain: Life impact
Endpoint subdomain: Functional outcomes
Primary endpoint: Cumulative incidence of CTEPH
Endpoint domain: Mortality/survival
Primary endpoint: PVO at PE diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sPAP at PE diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tube feeding permanence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FOIS scores progress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity levels of Dysphagia protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total adverse perinatal outcome
Endpoint domain: Adverse events/effects
Primary endpoint: preterm birth
Endpoint domain: Adverse events/effects
Primary endpoint: need for phototherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Knee adduction moment (KAM) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Week 52 response measured by ASDAS‐MI, ASAS40 and BASDAI50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Positive and Negative Syndrome Scale-Total
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dizziness intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DHI (Disability Handicap Inventory)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Freedom from repeat intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allergy development prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: SVR24 achievement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nonfatal overdose events
Endpoint domain: Adverse events/effects
Primary endpoint: arrests
Endpoint domain: Adverse events/effects
Primary endpoint: executive functioning problems
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: emotional self-control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: adaptive classroom behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: graft success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interrater reliability of SASv2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive FL test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area directly fused to the endplate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical seizure control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microgroove height change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microgroove width change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: taper interlock strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craving Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transcutaneous partial pressure of oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-minutes walk test improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of macrophage autophagy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increased sputum IL-10 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduced IL-4 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of G4 lymphopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Supragingival calculus removal time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Utilization of CBT skills post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Composite of heart failure readmission or all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decrease in posttraumatic stress symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant improvement in PTSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective stress levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median VSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during change of wound dressing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of dressing changes per day of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean number of coagulations with hemostatic forceps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: rate of hemostasis achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: rates of grade ≥3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Prognostic effect of genomic signature
Endpoint domain: Mortality/survival
Primary endpoint: time to task failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 10-year cumulative incidence of IBTR
Endpoint domain: Mortality/survival
Primary endpoint: Breast cancer-specific survival at 10 years
Endpoint domain: Mortality/survival
Primary endpoint: patient-reported outcome measures scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: recurrence detection
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Ocular Pain Assessment (OPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of adequate bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined outcome of death or ECMO
Endpoint domain: Mortality/survival
Primary endpoint: Mean time to successful intravenous cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASI 75/90 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood lactic acid content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Creatine phosphokinase (CK) content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subjective strength grade
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: 12-month postpartum retention
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: lost-to-follow-up (LTFU) rates
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Proportion of patients achieving an exercise amount of 12.5 MET or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of patients with OUD receiving MOUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suppression of estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: self-reported 7-day PPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first severe clinical exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean shear bond strength value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-stent restenosis (ISR)
Endpoint domain: Mortality/survival
Primary endpoint: Target lesion revascularization (TLR)
Endpoint domain: Mortality/survival
Primary endpoint: Duration of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under the curve (AUC) of abnormal HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive Predictive Value (PPV) for capturing GCSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity for capturing GCSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Specificity for capturing GCSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: cell proliferation in the lower colonic crypt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of CT imaging
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CT yield
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: cardiovascular death, MI, or stroke
Endpoint domain: Mortality/survival
Primary endpoint: ankle muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fugl–Meyer score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until block begins to wear off
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognosis of patients selected for SHERBOC
Endpoint domain: Mortality/survival
Primary endpoint: Decreased IEDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Reduction in area of capsaicin-induced allodynia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection rate of sentinel lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Repeat point prevalence abstinence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: YMRS total score mean difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidents of sexual violence perpetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence rates of sexual violence victimization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall adverse reaction rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of systemic adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Local adverse reaction rate
Endpoint domain: Adverse events/effects
Primary endpoint: Fractional Anisotropy (FA) in edematous CST at 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fractional Anisotropy (FA) in edematous CST at Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Depressive symptom improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in visceral lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood pressure under control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: worst pain of week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: walking on the Activity Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SBM (spontaneous bowel movements)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient assessment of constipation QOL (quality of life)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in forsaken daily activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Retention in therapy
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: cardiorespiratory fitness peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: isokinetic torque peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chair stand test completion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responses to joint attention (RJA) abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of joint attention (IJA) abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of borderline zone 1 NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean percent reduction in MADRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-test utilization of anticoagulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: appropriate antithrombotic management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum changes in HIV‐1 RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission status at follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pre-sleep cognitive arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Brief Pain Inventory (BPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in CPM-pressure in the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in CPM-pain in the hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from syncope within 1 year of follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Ontario Rotator Cuff (WORC) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acromiohumeral interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive primary outcomes reported
Endpoint domain: Mortality/survival
Primary endpoint: Rate of remaining in sinus rhythm (SR) at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite outcome of survival free of stroke and AF
Endpoint domain: Mortality/survival
Primary endpoint: levels of reactance to the message content
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: superficial cells count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: VHI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: symptoms of vaginal atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: spO2 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type 1 collagen C-terminal telopeptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of analgesics taken
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: IgG mean concentrations (GMCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Opsonophagocytic geometric mean titres (GMTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of IgG ≥ 0.35 µg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cycling distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General Self‐Efficacy Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Guide to Performing Intramuscular Injections scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response on day three
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial hedonic scales
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Willingness to take the same solution again
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: peri-implant soft tissue inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OYC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: benefits of early antibiotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in triglycerides (TGs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduction of major risk factors for recurrent stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Performance in oral and dental hygiene-related behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gallbladder breach rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: docking time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes